TWI799959B - Cd40激動劑抗體和使用方法 - Google Patents
Cd40激動劑抗體和使用方法 Download PDFInfo
- Publication number
- TWI799959B TWI799959B TW110130787A TW110130787A TWI799959B TW I799959 B TWI799959 B TW I799959B TW 110130787 A TW110130787 A TW 110130787A TW 110130787 A TW110130787 A TW 110130787A TW I799959 B TWI799959 B TW I799959B
- Authority
- TW
- Taiwan
- Prior art keywords
- methods
- agonist antibodies
- agonist
- antibodies
- Prior art date
Links
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2020110536 | 2020-08-21 | ||
WOPCT/CN2020/110536 | 2020-08-21 | ||
CN202110904019.9 | 2021-08-06 | ||
CN202110904019 | 2021-08-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW202222833A TW202222833A (zh) | 2022-06-16 |
TWI799959B true TWI799959B (zh) | 2023-04-21 |
Family
ID=83062602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW110130787A TWI799959B (zh) | 2020-08-21 | 2021-08-20 | Cd40激動劑抗體和使用方法 |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI799959B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106554414A (zh) * | 2015-09-18 | 2017-04-05 | 科济生物医药(上海)有限公司 | 抗cd19全人抗体以及靶向cd19的免疫效应细胞 |
WO2018115859A1 (en) * | 2016-12-20 | 2018-06-28 | Kymab Limited | Multispecific antibody with combination therapy for immuno-oncology |
CN108373505A (zh) * | 2018-04-20 | 2018-08-07 | 北京智仁美博生物科技有限公司 | 抗il-4r抗体及其用途 |
CN109071665A (zh) * | 2016-04-18 | 2018-12-21 | 塞德斯医疗公司 | 结合人cd40的激动性抗体及其用途 |
-
2021
- 2021-08-20 TW TW110130787A patent/TWI799959B/zh active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106554414A (zh) * | 2015-09-18 | 2017-04-05 | 科济生物医药(上海)有限公司 | 抗cd19全人抗体以及靶向cd19的免疫效应细胞 |
CN109071665A (zh) * | 2016-04-18 | 2018-12-21 | 塞德斯医疗公司 | 结合人cd40的激动性抗体及其用途 |
WO2018115859A1 (en) * | 2016-12-20 | 2018-06-28 | Kymab Limited | Multispecific antibody with combination therapy for immuno-oncology |
CN108373505A (zh) * | 2018-04-20 | 2018-08-07 | 北京智仁美博生物科技有限公司 | 抗il-4r抗体及其用途 |
Also Published As
Publication number | Publication date |
---|---|
TW202222833A (zh) | 2022-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202019709D0 (en) | Anti-Coronavirus antibodies and methods of use | |
DK3966207T3 (da) | Phenylaminopyrimidinamid-autophagi-hæmmere og fremgangsmåder til anvendelse deraf | |
DK3966206T3 (da) | Heteroarylaminopyrimidinamid-autophagihæmmere og fremgangsmåder til anvendelse deraf | |
DK3618928T3 (da) | Anti-Sortilin-antistoffer og fremgangsmåder til anvendelse deraf | |
IL279475A (en) | Actonucleotidase inhibitors and methods of using them | |
IL276711A (en) | Arginase inhibitors and methods of using them | |
IL284640A (en) | PCSK9 inhibitors and methods of using them | |
KR20220035452A (ko) | 면역조절 항체 및 이의 사용 방법 | |
EP3765006A4 (en) | ARGINASE INHIBITORS AND METHODS OF USE | |
IL287751A (en) | kcnt1 inhibitors and methods of use | |
SG11202112158YA (en) | Kcnt1 inhibitors and methods of use | |
IL284661A (en) | pcsk9 inhibitors and methods of using them | |
SG11202112226WA (en) | Acss2 inhibitors and methods of use thereof | |
EP3810615A4 (en) | ARGINASE INHIBITORS AND METHODS OF USE | |
EP3897622A4 (en) | ARGINASE INHIBITORS AND METHODS OF USE | |
KR20220035450A (ko) | Irak 억제제 및 이의 제조 방법과 용도 | |
EP3846808A4 (en) | PAPD5 INHIBITORS AND METHODS OF USE THEREOF | |
IL280924A (en) | Arginase inhibitors and methods of using them | |
KR20220035322A (ko) | Pi4-키나아제 억제제 및 이의 사용 방법 | |
TWI799959B (zh) | Cd40激動劑抗體和使用方法 | |
IL308260A (en) | Antibodies against Tigit and methods of using them | |
EP4084789A4 (en) | PPAR AGONIST COMPLEX AND METHODS OF USE | |
SG11202108503PA (en) | Arginase inhibitors and methods of use thereof | |
GB201818477D0 (en) | Tissue plasminogen activator antibodies and method of use thereof | |
IL309349A (en) | Antibodies against interleukin 9 and methods of using them |